AMBONI, Marianna
 Distribuzione geografica
Continente #
AS - Asia 13.215
NA - Nord America 7.611
EU - Europa 2.656
SA - Sud America 1.047
AF - Africa 121
OC - Oceania 57
Continente sconosciuto - Info sul continente non disponibili 6
Totale 24.713
Nazione #
HK - Hong Kong 9.080
US - Stati Uniti d'America 7.441
SG - Singapore 1.814
CN - Cina 811
BR - Brasile 797
VN - Vietnam 669
IT - Italia 483
RU - Federazione Russa 412
UA - Ucraina 353
DE - Germania 331
IE - Irlanda 224
TR - Turchia 199
FR - Francia 197
KR - Corea 162
SE - Svezia 157
GB - Regno Unito 139
EE - Estonia 107
AR - Argentina 99
IN - India 98
CA - Canada 85
BD - Bangladesh 77
FI - Finlandia 74
JP - Giappone 53
EC - Ecuador 43
MX - Messico 43
IQ - Iraq 41
ID - Indonesia 35
PL - Polonia 35
ZA - Sudafrica 33
PK - Pakistan 32
AU - Australia 31
NL - Olanda 28
VE - Venezuela 27
CO - Colombia 26
NZ - Nuova Zelanda 24
ES - Italia 23
UZ - Uzbekistan 21
CZ - Repubblica Ceca 18
CL - Cile 17
PY - Paraguay 17
KE - Kenya 16
MA - Marocco 16
AT - Austria 15
MY - Malesia 13
SA - Arabia Saudita 12
TN - Tunisia 11
DZ - Algeria 10
PH - Filippine 10
AZ - Azerbaigian 9
PE - Perù 9
AE - Emirati Arabi Uniti 8
BE - Belgio 8
ET - Etiopia 8
IL - Israele 8
JM - Giamaica 8
JO - Giordania 8
AL - Albania 7
DO - Repubblica Dominicana 7
LB - Libano 7
LT - Lituania 7
OM - Oman 7
CH - Svizzera 6
EG - Egitto 6
KZ - Kazakistan 6
NP - Nepal 6
UY - Uruguay 6
BA - Bosnia-Erzegovina 5
BO - Bolivia 5
EU - Europa 5
BG - Bulgaria 4
GT - Guatemala 4
HN - Honduras 4
HR - Croazia 4
SN - Senegal 4
BH - Bahrain 3
BS - Bahamas 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
LY - Libia 3
ME - Montenegro 3
MN - Mongolia 3
PA - Panama 3
RS - Serbia 3
TH - Thailandia 3
BW - Botswana 2
CY - Cipro 2
DK - Danimarca 2
IR - Iran 2
KH - Cambogia 2
LC - Santa Lucia 2
LK - Sri Lanka 2
MD - Moldavia 2
MM - Myanmar 2
NI - Nicaragua 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SY - Repubblica araba siriana 2
TJ - Tagikistan 2
ZW - Zimbabwe 2
AM - Armenia 1
Totale 24.686
Città #
Hong Kong 9.062
Ann Arbor 1.105
San Jose 863
Singapore 858
Princeton 518
Chandler 510
Wilmington 468
Ashburn 442
Jacksonville 432
Dallas 424
Houston 258
Dublin 210
Woodbridge 201
Council Bluffs 194
Beijing 175
Izmir 166
Ho Chi Minh City 165
The Dalles 160
Lauterbourg 155
Dong Ket 136
Hanoi 131
Nanjing 112
Moscow 111
Tallinn 107
Andover 104
Boardman 86
Los Angeles 84
São Paulo 72
Salerno 69
New York 66
Munich 65
Pellezzano 64
Düsseldorf 55
Norwalk 53
Santa Clara 50
Dearborn 44
Shenyang 43
Naples 41
Nanchang 39
Tokyo 36
Fairfield 34
Mestre 34
Haiphong 31
Milan 31
San Francisco 30
Frankfurt am Main 29
Hebei 29
Rio de Janeiro 29
Montreal 28
Memphis 27
Redwood City 26
Warsaw 26
Jiaxing 25
Da Nang 24
Nuremberg 23
Rome 23
Chennai 22
Brooklyn 21
Changsha 21
Pune 21
Orem 20
Amsterdam 19
Tashkent 19
Boston 18
San Diego 18
Tianjin 18
Atlanta 17
Baghdad 17
Washington 17
Denver 16
Poplar 16
Belo Horizonte 15
London 15
Nairobi 15
Ankara 14
Brasília 14
Casoria 14
Chicago 14
Curitiba 14
Guarulhos 14
Phoenix 14
Porto Alegre 14
Quito 14
Stockholm 14
Biên Hòa 13
Guangzhou 13
Seoul 13
Turku 13
Caracas 12
Guayaquil 12
Seattle 12
Auckland 11
Cape Town 11
Sydney 11
Thái Bình 11
Campinas 10
Columbus 10
Dhaka 10
Manchester 10
Mexico City 10
Totale 19.030
Nome #
Step length predicts executive dysfunction in Parkinson’s disease: a 3-year prospective study 995
Sex Differences in Parkinson’s Disease: From Bench to Bedside 651
Quantitative gait assessment in Parkinsonian patients with or without Mild Cognitive Impairment 612
Prevalence and associated features of self-reported freezing of gait in Parkinson disease: The DEEP FOG study 597
Gender differences in microRNA expression in levodopa-naive PD patients 560
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease. 547
Gait Analysis in Progressive Supranuclear Palsy Phenotypes. 526
Combined regional T1w/T2w ratio and voxel-based morphometry in multiple system atrophy: A follow-up study 506
Treatment of nocturnal disturbances and excessive daytime sleepiness in Parkinson's disease. 433
Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease 422
Fist-Palm Test May Identify Mild Cognitive Impairment and Freezing of Gait in Parkinson's Disease: A Machine Learning Approach 398
The most effective way to obtain long-term memory is to increase first presentation duration of single words 371
Resting-state brain connectivity in patients with Parkinson's disease and freezing of gait. 325
A longitudinal study of cognitive dysfunction in patients affected by Parkinson’s disease with and without freezing of gait 323
Relationship Between Orthostatic Hypotension and Cognitive Functions in Multiple System Atrophy: A Longitudinal Study 294
Effect of Global Postural Rehabilitation program on spatiotemporal gait parameters of parkinsonian patients: a three-dimensional motion analysis study. 286
Dual-task-related gait patterns as possible marker of precocious and subclinical cognitive alterations in Parkinson disease 277
Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients. 270
Classifying Different Stages of Parkinson’s Disease Through Random Forests 262
Metabolomics in Parkinson's disease 260
Diagnostics and Ecological Validity of the Italian Version of the Parkinson's Disease Cognitive Rating Scale 244
Intraocular pressure and choroidal thickness postural changes in multiple system atrophy and Parkinson's disease 240
Validation of an Italian version of the 40-item University of Pennsylvania Smell Identification Test that is physician administered: our experience on one hundred and thirty-eight healthy subjects 221
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients 213
Lower serum uric acid is associated with mild cognitive impairment in early Parkinson's disease: a 4-year follow-up study 210
A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations. 203
Validation of the Italian version of carers’ quality-of-life questionnaire for parkinsonism (PQoL Carer) in progressive supranuclear palsy 197
Anxiety in early Parkinson's disease: Validation of the Italian observer-rated version of the Parkinson Anxiety Scale (OR-PAS) 195
Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkindisease 193
Apathy in untreated, de novo patients with Parkinson’s disease: validation study of Apathy Evaluation Scale 183
Olfaction in Homozygous and Heterozygous SYNJ1 Arg258Gln Mutation Carriers 178
Measurements of Postural Sway to Classify Freezing of Gait in Parkinson's Disease 173
Machine learning can detect the presence of Mild cognitive impairment in patients affected by Parkinson’s Disease 173
A Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease 169
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study 163
Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease 160
A two-year follow-up study of executive dysfunctions in parkinsonian patients with freezing of gait at on-state. 158
A longitudinal study on the effects of COVID-19 pandemic on non-motor symptoms in Parkinson's disease 158
A quantitative analysis of muscular co-activation on EMG signals in spastic patients treated with Botulinum toxin 155
An easy tool to improve accuracy in pre-diagnostic Parkinson's disease population 154
Quitting smoking: An early non-motor feature of Parkinson's disease? 148
Increased bilirubin levels in de novo Parkinson's disease 148
Serum uric acid is associated with apathy in early, drug-naïve Parkinson’s disease 148
Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study 147
Abnormal eating behaviors in progressive supranuclear palsy. 145
Pisa syndrome in Parkinson's disease and parkinsonism: clinical features, pathophysiology, and treatment 145
Biomechanics Parameters of Gait Analysis to Characterize Parkinson's Disease: A Scoping Review 142
Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients. 142
Association between dopaminergic dysfunction and anxiety in de novo Parkinson's disease 142
Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease 140
Caffeine consumption and the 4-year progression of de novo Parkinson's disease 139
Machine learning can predict mild cognitive impairment in Parkinson's disease 135
Bisphenol A glucuronidation in patients with Parkinson's disease 135
Is serum uric acid related to non-motor symptoms in de-novo Parkinson's disease patients? 133
Resting-state functional connectivity associated with mild cognitive impairment in Parkinson’s disease 130
The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients. 128
Clinical and neurological abnormalities in adult celiac disease. 128
The non-motor side of the honeymoon period of Parkinson's disease and its relationship with quality of life: A 4-year longitudinal study 127
Freezing of gait and executive functions in patients with Parkinson’s disease 127
Gender and non motor fluctuations in Parkinson's disease: A prospective study 125
Assessment of apathy minimising the effect of motor dysfunctions in Parkinson’s disease: a validation study of the dimensional apathy scale 124
Classifying patients affected by Parkinson’s disease into freezers or non-freezers through machine learning 120
Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson’s disease 116
Short-latency afferent inhibition in patients with Parkinson’s disease and freezing of gait 115
Cognitive correlates of “pure apathy” in Parkinson's disease 114
A metabolomic signature of treated and drug-naïve patients with Parkinson’s disease: a pilot study 114
Comparing PIGD and Akinetic-Rigid subtyping of Parkinson Disease and their stability over time 113
Regional Gray Matter Atrophy in Patients with Parkinson Disease and Freezing of Gait. 113
“Response to Apomorphine in early Parkinson’s disease”. 112
Mutation in theSYNJ1Gene Associated with Autosomal Recessive, Early-Onset Parkinsonism 111
The use of University of Pennsylvania Smell Identification Test in the diagnosis of Parkinson's disease in Italy. 111
Apathy in Parkinson's disease: differences between caregiver's report and self-evaluation 111
Presence and progression of non-motor symptoms in relation to uric acid inde novoParkinson's disease 110
Segmental progression of cardinal motor symptoms in Parkinson's disease: A pilot study suggesting a practical approach to rate disease course in the early stages. 107
Gait patterns in Parkinsonian patients with or without mild cognitive impairment. 106
Relationship between apathy and cognitive dysfunctions in de novo untreated Parkinson's disease: a prospective longitudinal study. 106
Clinical clusters and dopaminergic dysfunction in de-novo Parkinson disease 106
Cerebellar and pyramidal dysfunctions, palpebral ptosis and weakness aspresenting symptoms of PARK-2 105
Music Therapy for Motor and Nonmotor Symptoms of Parkinson's Disease: A Prospective, Randomized, Controlled, Single-Blinded Study 105
Resting-state brain networks in patients with Parkinson's disease and impulse control disorders 105
Uric acid relates to dopamine transporter availability in Parkinson's disease. 103
Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naïve Parkinson's disease. 103
The "eye of the tiger" sign in pure akinesia with gait freezing. 102
Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients 101
Gait patterns and cognition in Parkinson's disease 101
The Role of Deep Learning and Gait Analysis in Parkinson’s Disease: A Systematic Review 100
Agreement between Optoelectronic System and Wearable Sensors for the Evaluation of Gait Spatiotemporal Parameters in Progressive Supranuclear Palsy 99
Gender differences in non-motor symptoms in early, drug naïve Parkinson's disease 98
Parkinson’s disease and the spectrum of Lewy body disease 97
Multiple system atrophy is associated with changes in peripheral insulin-like growth factor system 95
Neuropsychological correlates of theory of mind in patients withearly Parkinson's disease. 94
Resting brain networks in patients with Parkinson's disease and freezing of gait 94
Comment on Szewczyk-Krolikowski et al.: The influence of age and gender on motor and non-motor features of early Parkinson's disease: Initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohort 94
Parkinsonism and essential tremor in a family with pseudo-dominant inheritance ofPARK2: an FP-CIT SPECT study 93
Ropinirole as a treatment of restless legs syndrome in patients on chronichemodialysis: an open randomized crossover trial versus levodopa sustainedrelease 93
Development of software tool for quantitative gait assessment in Parkinsonian patients with and without Mild Cognitive Impairment 92
Do Subjective Memory Complaints Herald the Onset of Mild Cognitive Impairment in Parkinson Disease? 91
Identification by [99mTc]ECD SPECT of anterior cingulate hypoperfusion in progressive supranuclear palsy, in comparison with Parkinson's disease 90
Screening performances of an 8-item UPSIT Italian version in the diagnosis of Parkinson's disease 89
Performing a short sway to distinguish Parkinsonisms 89
Totale 19.551
Categoria #
all - tutte 72.302
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.302


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021180 0 0 0 0 0 0 0 0 0 0 0 180
2021/2022829 9 2 12 14 6 1 7 33 112 117 120 396
2022/20231.274 154 67 37 114 203 295 11 111 185 12 61 24
2023/2024772 44 105 40 42 29 90 25 63 35 57 108 134
2024/20252.220 78 20 31 180 80 182 273 203 320 263 296 294
2025/202615.454 1.587 4.538 3.992 682 920 437 1.312 305 431 884 248 118
Totale 25.115